Bristol, Sanofi and Novartis drugs to shine among 2015 launches

LONDON, March 23 (Reuters) - Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion-plus sales potential, according to a Thomson Reuters analysis.